A phase I trial of vorinostat and alvocidib in patients with relapsed, refractory, or poor prognosis acute leukemia, or refractory anemia with excess blasts-2. (Q36745599)
Jump to navigation
Jump to search
scientific article published on 20 March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I trial of vorinostat and alvocidib in patients with relapsed, refractory, or poor prognosis acute leukemia, or refractory anemia with excess blasts-2. |
scientific article published on 20 March 2013 |
Statements
1 reference
A phase I trial of vorinostat and alvocidib in patients with relapsed, refractory, or poor prognosis acute leukemia, or refractory anemia with excess blasts-2. (English)
1 reference
John D Roberts
1 reference
Beata Holkova
1 reference
Jeffrey G Supko
1 reference
Matthew M Ames
1 reference
Joel M Reid
1 reference
Geoffrey I Shapiro
1 reference
Edward Brent Perkins
1 reference
Viswanathan Ramakrishnan
1 reference
Mary Beth Tombes
1 reference
Connie Honeycutt
1 reference
Renee M McGovern
1 reference
Maciej Kmieciak
1 reference
Ellen Shrader
1 reference
Martha D Wellons
1 reference
Heidi Sankala
1 reference
Austin Doyle
1 reference
John Wright
1 reference
Steven Grant
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference